vs
B&G Foods, Inc.(BGS)与RadNet, Inc.(RDNT)财务数据对比。点击上方公司名可切换其他公司
RadNet, Inc.的季度营收约是B&G Foods, Inc.的1.2倍($547.7M vs $439.3M),RadNet, Inc.净利率更高(-0.1% vs -4.4%,领先4.2%),RadNet, Inc.同比增速更快(14.8% vs -4.7%),过去两年RadNet, Inc.的营收复合增速更高(12.6% vs -12.8%)
B&G Foods是总部位于美国新泽西州帕西帕尼的品牌食品控股企业,创立于1996年,成立初衷是收购1889年诞生于曼哈顿的酸黄瓜、调味酱及调味品生产商Bloch & Guggenheimer,如今在北美食品领域拥有众多知名品牌。
RadNet是美国领先的放射医疗服务企业,总部位于加利福尼亚州洛杉矶,是美国规模最大的独立固定地址诊断影像中心运营商,按网点数量及年度影像业务收入计均居行业首位。截至2025年,该公司在全美8个州持有或运营超400家影像中心,提供门诊诊断影像服务。
BGS vs RDNT — 直观对比
营收规模更大
RDNT
是对方的1.2倍
$439.3M
营收增速更快
RDNT
高出19.5%
-4.7%
净利率更高
RDNT
高出4.2%
-4.4%
两年增速更快
RDNT
近两年复合增速
-12.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $439.3M | $547.7M |
| 净利润 | $-19.1M | $-597.0K |
| 毛利率 | 22.5% | — |
| 营业利润率 | 2.5% | 5.1% |
| 净利率 | -4.4% | -0.1% |
| 营收同比 | -4.7% | 14.8% |
| 净利润同比 | -356.5% | -111.2% |
| 每股收益(稀释后) | $-0.24 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BGS
RDNT
| Q4 25 | — | $547.7M | ||
| Q3 25 | $439.3M | $522.9M | ||
| Q2 25 | $424.4M | $498.2M | ||
| Q1 25 | $425.4M | $471.4M | ||
| Q4 24 | $551.6M | $477.1M | ||
| Q3 24 | $461.1M | $461.1M | ||
| Q2 24 | $444.6M | $459.7M | ||
| Q1 24 | $475.2M | $431.7M |
净利润
BGS
RDNT
| Q4 25 | — | $-597.0K | ||
| Q3 25 | $-19.1M | $5.4M | ||
| Q2 25 | $-9.8M | $14.5M | ||
| Q1 25 | $835.0K | $-37.9M | ||
| Q4 24 | $-222.4M | $5.3M | ||
| Q3 24 | $7.5M | $3.2M | ||
| Q2 24 | $3.9M | $-3.0M | ||
| Q1 24 | $-40.2M | $-2.8M |
毛利率
BGS
RDNT
| Q4 25 | — | — | ||
| Q3 25 | 22.5% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | 21.2% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | 20.7% | — | ||
| Q1 24 | 22.9% | — |
营业利润率
BGS
RDNT
| Q4 25 | — | 5.1% | ||
| Q3 25 | 2.5% | 5.2% | ||
| Q2 25 | 5.2% | 6.2% | ||
| Q1 25 | 8.4% | -5.1% | ||
| Q4 24 | -46.6% | 5.1% | ||
| Q3 24 | 11.1% | 7.4% | ||
| Q2 24 | 9.9% | 7.6% | ||
| Q1 24 | -3.3% | 2.6% |
净利率
BGS
RDNT
| Q4 25 | — | -0.1% | ||
| Q3 25 | -4.4% | 1.0% | ||
| Q2 25 | -2.3% | 2.9% | ||
| Q1 25 | 0.2% | -8.0% | ||
| Q4 24 | -40.3% | 1.1% | ||
| Q3 24 | 1.6% | 0.7% | ||
| Q2 24 | 0.9% | -0.6% | ||
| Q1 24 | -8.5% | -0.6% |
每股收益(稀释后)
BGS
RDNT
| Q4 25 | — | $0.00 | ||
| Q3 25 | $-0.24 | $0.07 | ||
| Q2 25 | $-0.12 | $0.19 | ||
| Q1 25 | $0.01 | $-0.51 | ||
| Q4 24 | $-2.81 | $0.08 | ||
| Q3 24 | $0.09 | $0.04 | ||
| Q2 24 | $0.05 | $-0.04 | ||
| Q1 24 | $-0.51 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $60.9M | $767.2M |
| 总债务越低越好 | $2.0B | $1.1B |
| 股东权益账面价值 | $470.7M | $1.1B |
| 总资产 | $2.9B | $3.8B |
| 负债/权益比越低杠杆越低 | 4.30× | 1.00× |
8季度趋势,按日历期对齐
现金及短期投资
BGS
RDNT
| Q4 25 | — | $767.2M | ||
| Q3 25 | $60.9M | $804.7M | ||
| Q2 25 | $54.1M | $833.2M | ||
| Q1 25 | $61.2M | $717.3M | ||
| Q4 24 | $50.6M | $740.0M | ||
| Q3 24 | $54.7M | $748.9M | ||
| Q2 24 | $40.3M | $741.7M | ||
| Q1 24 | $42.5M | $527.0M |
总债务
BGS
RDNT
| Q4 25 | — | $1.1B | ||
| Q3 25 | $2.0B | $1.1B | ||
| Q2 25 | $2.0B | $1.1B | ||
| Q1 25 | $2.0B | $1.0B | ||
| Q4 24 | $2.0B | $1.0B | ||
| Q3 24 | $2.1B | $1.0B | ||
| Q2 24 | $2.0B | $1.0B | ||
| Q1 24 | $2.0B | $834.6M |
股东权益
BGS
RDNT
| Q4 25 | — | $1.1B | ||
| Q3 25 | $470.7M | $1.1B | ||
| Q2 25 | $501.4M | $932.3M | ||
| Q1 25 | $513.1M | $898.1M | ||
| Q4 24 | $524.8M | $902.3M | ||
| Q3 24 | $755.3M | $895.3M | ||
| Q2 24 | $765.0M | $881.0M | ||
| Q1 24 | $781.2M | $873.0M |
总资产
BGS
RDNT
| Q4 25 | — | $3.8B | ||
| Q3 25 | $2.9B | $3.7B | ||
| Q2 25 | $2.9B | $3.5B | ||
| Q1 25 | $3.0B | $3.3B | ||
| Q4 24 | $3.0B | $3.3B | ||
| Q3 24 | $3.4B | $3.3B | ||
| Q2 24 | $3.4B | $3.2B | ||
| Q1 24 | $3.4B | $3.0B |
负债/权益比
BGS
RDNT
| Q4 25 | — | 1.00× | ||
| Q3 25 | 4.30× | 1.04× | ||
| Q2 25 | 3.97× | 1.18× | ||
| Q1 25 | 3.91× | 1.12× | ||
| Q4 24 | 3.85× | 1.13× | ||
| Q3 24 | 2.75× | 1.14× | ||
| Q2 24 | 2.67× | 1.17× | ||
| Q1 24 | 2.61× | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-64.6M | $84.2M |
| 自由现金流经营现金流 - 资本支出 | $-70.7M | — |
| 自由现金流率自由现金流/营收 | -16.1% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $54.8M | — |
8季度趋势,按日历期对齐
经营现金流
BGS
RDNT
| Q4 25 | — | $84.2M | ||
| Q3 25 | $-64.6M | $52.8M | ||
| Q2 25 | $17.8M | $120.3M | ||
| Q1 25 | $52.7M | $41.5M | ||
| Q4 24 | $80.3M | $42.5M | ||
| Q3 24 | $4.2M | $57.4M | ||
| Q2 24 | $11.3M | $116.0M | ||
| Q1 24 | $35.1M | $17.1M |
自由现金流
BGS
RDNT
| Q4 25 | — | — | ||
| Q3 25 | $-70.7M | — | ||
| Q2 25 | $11.5M | — | ||
| Q1 25 | $42.4M | — | ||
| Q4 24 | $71.7M | — | ||
| Q3 24 | $-679.0K | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $27.5M | — |
自由现金流率
BGS
RDNT
| Q4 25 | — | — | ||
| Q3 25 | -16.1% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | -0.1% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 5.8% | — |
资本支出强度
BGS
RDNT
| Q4 25 | — | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.6% | — |
现金转化率
BGS
RDNT
| Q4 25 | — | — | ||
| Q3 25 | — | 9.75× | ||
| Q2 25 | — | 8.33× | ||
| Q1 25 | 63.17× | — | ||
| Q4 24 | — | 7.96× | ||
| Q3 24 | 0.56× | 17.89× | ||
| Q2 24 | 2.87× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BGS
| Specialty Segment | $150.5M | 34% |
| Meals Segment | $110.0M | 25% |
| Spices And Flavor Solutions Segment | $101.4M | 23% |
| Frozen And Vegetables Segment | $77.4M | 18% |
RDNT
| Commercial Insurance1 | $301.0M | 55% |
| Medicare1 | $129.2M | 24% |
| Capitation Arrangements | $31.9M | 6% |
| Health Care Other | $20.4M | 4% |
| Digital Health | $16.4M | 3% |
| Other | $15.2M | 3% |
| Medicaid1 | $14.0M | 3% |
| Workers Compensation Personal Injury1 | $12.3M | 2% |
| Health Care Management Service | $7.5M | 1% |